12/16/2024
6:00 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024
6:05 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
6:55 PM | MediWound (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
10/23/2024
1:57 PM | MediWound (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
10/01/2024
7:23 AM | MediWound (Subject)
Yelin Lapidot Holdings Management Ltd. (Filed by)
| Form SC 13G | |
09/09/2024
11:15 PM | MediWound (Filer)
| Form EFFECT | |
09/09/2024
3:47 PM | MediWound (Filer)
| Form 424B3 | |
|
08/29/2024
3:44 PM | MediWound (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
08/15/2024
3:20 PM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:07 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
6:21 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024
7:53 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2024
3:30 PM | MediWound (Subject)
Molnlycke Health Care AB (Filed by)
| Form SC 13D | |
07/19/2024
3:01 PM | Access Industries Holdings LLC (Filed by)
MediWound (Subject)
| Form SC 13D/A | |
07/16/2024
6:35 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
6:05 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
4:43 PM | MediWound (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
07/09/2024
3:05 PM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
6:05 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
6:22 PM | MediWound (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
03/21/2024
7:08 AM | MediWound (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/21/2024
6:05 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:43 PM | MediWound (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
02/12/2024
6:05 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024
6:05 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
6:00 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
6:05 AM | Deep Insight Limited Partnership (Filed by)
MediWound (Subject)
| Form SC 13G/A | |
01/08/2024
5:35 AM | Israel Biotech Fund II, L.P. (Filed by)
MediWound (Subject)
| Form SC 13G/A | |
12/28/2023
6:05 AM | MediWound (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
